Download PDF
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice
DOI: 10.1055/s-0044-1781437
Conference Abstracts
Editorial

Abstracts of the Diabetes and Ramadan International Alliance (Virtual) Conference 2024, 12 to 13 January 2024

Mohamed Hassanein 
1   Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, United Arab Emirates
2   Department of Medicine, Mohamed Bin Rashid University, Dubai, United Arab Emirates
3   Department of Medicine, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates
,
Bachar Afandi
4   Department of Endocrinology, Tawam Hospital, SEHA, Al Ain, United Arab Emirates
5   Department of Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
› Author Affiliations Financial Support and Sponsorship Unconditional educational grants from several government and pharmaceutical agents support the DaR for the conference.
› Further Information
   Permissions and Reprints

Abstract

The Diabetes and Ramadan (DAR) International Alliance was created to coordinate the research work and align the expert opinion on the subject worldwide. DAR holds an annual conference for the early presentation of new studies, consensus statements, and clinical practice guidelines. This year’s conference was held virtually to attract a larger audience. The conference was held on the 12th and 13th of January 2024. This article presents the advance abstracts of the conference’s communications. The abstracts are grouped under themes to facilitate reading. In conclusion, diabetes remains the most extensively studied health impact of Ramadan fasting. Continued interest is evolving around the newer therapeutic agents and technologies.

Keywords

Ramadan fasting - type 2 diabetes - type 1 diabetes - digital technology - insulin - SGLT2 inhibitors - glycemic metrics

Authors’ Contributions

The conference abstracts were compiled by the scientific committee, which acted as the guest editors. The DAR International Alliance mandates that all named authors on submitted abstracts comply with the four ICMJE authorship criteria.


Compliance with Ethical Principles

The abstracts are accepted on the proviso that all human research was conducted according to the appropriate ethical principles, with prior ethical approvals and patient-informed consent.




Publication History

Article published online:
11 April 2024

© 2024. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India